Ectasia

Results: 31



#Item
11FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and the Ophthalmic Devices Panel of the Medical Devices

FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and the Ophthalmic Devices Panel of the Medical Devices

Add to Reading List

Source URL: www.fda.gov

Language: English
12Microsoft Word - MSAC App 1083 final clean.doc

Microsoft Word - MSAC App 1083 final clean.doc

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2014-08-08 00:29:15
13Microsoft Word - draft MSAC 1106 APC one page summary.doc

Microsoft Word - draft MSAC 1106 APC one page summary.doc

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2014-08-08 01:10:30
14Cross-linking procedure UV-X™ 1000 Indications  Progressive keratoconus  Iatrogenic ectasia (e.g. after LASIK)  Pellucid marginal degeneration

Cross-linking procedure UV-X™ 1000 Indications  Progressive keratoconus  Iatrogenic ectasia (e.g. after LASIK)  Pellucid marginal degeneration

Add to Reading List

Source URL: www.medsrl.com.ar

Language: English - Date: 2014-05-14 11:39:45
15Cross-linking procedure UV-X™ 2000 Indications  Progressive keratoconus  Iatrogenic ectasia (e.g. after LASIK)  Pellucid marginal degeneration

Cross-linking procedure UV-X™ 2000 Indications  Progressive keratoconus  Iatrogenic ectasia (e.g. after LASIK)  Pellucid marginal degeneration

Add to Reading List

Source URL: www.medsrl.com.ar

Language: English - Date: 2014-05-14 11:39:51
16FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and the Ophthalmic Devices Panel of the Medical Devices

FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and the Ophthalmic Devices Panel of the Medical Devices

Add to Reading List

Source URL: www.fda.gov

Language: English
17Temporary Compliance Waiver Notice At the time of initial posting on March 4th, 2015, the attached PDF document may not be fully accessible to readers using assistive technology. A fully accessible version of the documen

Temporary Compliance Waiver Notice At the time of initial posting on March 4th, 2015, the attached PDF document may not be fully accessible to readers using assistive technology. A fully accessible version of the documen

Add to Reading List

Source URL: www.fda.gov

Language: English
18Article ID: WMC004806  ISSN[removed]Benign breast disorders: An insight with a detailed literature review

Article ID: WMC004806 ISSN[removed]Benign breast disorders: An insight with a detailed literature review

Add to Reading List

Source URL: www.webmedcentral.com

Language: English - Date: 2015-01-23 00:39:11
19Published by Ministry of Health, Labour and Welfare Translated by Pharmaceuticals and Medical Devices Agency

Published by Ministry of Health, Labour and Welfare Translated by Pharmaceuticals and Medical Devices Agency

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2014-09-16 03:12:42
20Introducing our Wichita, Kansas 2014 NF Heroes - Taylor and Michael Dudrey Taylor and Michael Dudrey were diagnosed with Neurofibromatosis type 1 the summer of[removed]Michael had always been referred to as our “birthmar

Introducing our Wichita, Kansas 2014 NF Heroes - Taylor and Michael Dudrey Taylor and Michael Dudrey were diagnosed with Neurofibromatosis type 1 the summer of[removed]Michael had always been referred to as our “birthmar

Add to Reading List

Source URL: www.nfnetwork.org

Language: English - Date: 2014-05-22 11:24:42